SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/14 – ‘R24’

On:  Tuesday, 2/10/15, at 4:45pm ET   ·   For:  12/31/14   ·   Accession #:  731766-15-7   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/12/14 for 12/31/13   ·   Next:  ‘10-K’ on 2/9/16 for 12/31/15   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/10/15  Unitedhealth Group Inc            10-K       12/31/14  111:26M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.49M 
 2: EX-10.2     Material Contract                                   HTML     35K 
 3: EX-10.3     Material Contract                                   HTML     83K 
 4: EX-10.32    Material Contract                                   HTML     57K 
 6: EX-21.1     Subsidiaries List                                   HTML    128K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML     34K 
 8: EX-24.1     Power of Attorney                                   HTML     40K 
 5: EX-12.1     Statement re: Computation of Ratios                 HTML     45K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     48K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     36K 
76: R1          Document and Entity Information Document            HTML     63K 
62: R2          Consolidated Balance Sheets                         HTML    152K 
73: R3          Consolidated Balance Sheet (Parenthetical)          HTML     68K 
80: R4          Consolidated Statements of Operations               HTML    123K 
101: R5          Consolidated Statements of Comprehensive Income     HTML     82K  
64: R6          Consolidated Statements of Changes in               HTML    113K 
                Shareholders' Equity                                             
72: R7          Consolidated Statements of Cash Flows               HTML    162K 
55: R8          Description of Business (Notes)                     HTML     33K 
45: R9          Basis of Presentation, Uses of Estimates and        HTML    128K 
                Significant Accounting Policies (Notes)                          
103: R10         Investments (Notes)                                 HTML    297K  
82: R11         Fair Value (Notes)                                  HTML    336K 
81: R12         Property, Plant, and Capitalized Software (Notes)   HTML     55K 
88: R13         Goodwill and Intangible Assets (Notes)              HTML    120K 
89: R14         Medical Cost Reserve Development and Medical Costs  HTML     61K 
                Payable (Notes)                                                  
86: R15         Commercial Paper and Long-Term Debt (Notes)         HTML    222K 
90: R16         Income Taxes (Notes)                                HTML    155K 
74: R17         Shareholders' Equity (Notes)                        HTML     57K 
77: R18         Share-Based Compensation (Notes)                    HTML    115K 
84: R19         Commitments and Contingencies (Notes)               HTML     58K 
111: R20         Segment Financial Information (Notes)               HTML    317K  
97: R21         Quarterly Financial Data (Unaudited) (Notes)        HTML     85K 
68: R22         Schedule I (Notes)                                  HTML    191K 
83: R23         Basis of Presentation, Uses of Estimates and        HTML    195K 
                Significant Accounting Policies (Policies)                       
70: R24         Fair Value Fair Value (Policies)                    HTML     48K 
36: R25         Basis of Presentation, Uses of Estimates and        HTML     88K 
                Significant Accounting Policies (Tables)                         
98: R26         Investments (Tables)                                HTML    300K 
107: R27         Fair Value (Tables)                                 HTML    329K  
50: R28         Property, Plant, and Capitalized Software (Tables)  HTML     53K 
49: R29         Goodwill and Intangible Assets (Tables)             HTML    123K 
53: R30         Medical Cost Reserve Development and Medical Costs  HTML     62K 
                Payable (Tables)                                                 
54: R31         Commercial Paper and Long-Term Debt (Tables)        HTML    226K 
57: R32         Income Taxes (Tables)                               HTML    177K 
25: R33         Shareholders' Equity (Tables)                       HTML     41K 
95: R34         Share-Based Compensation (Tables)                   HTML    115K 
66: R35         Commitments and Contingencies Commitments and       HTML     43K 
                Contingencies (Tables)                                           
69: R36         Segment Financial Information (Tables)              HTML    302K 
40: R37         Quarterly Financial Data (Unaudited) (Tables)       HTML     84K 
110: R38         Schedule I (Tables)                                 HTML    197K  
17: R39         Basis of Presentation, Uses of Estimates and        HTML     84K 
                Significant Accounting Policies (Details)                        
59: R40         Basis of Presentation, Uses of Estimates and        HTML     46K 
                Significant Accounting Policies Medicare Part D                  
                (Details)                                                        
100: R41         Basis of Presentation, Uses of Estimates and        HTML     45K  
                Significant Accounting Policies Useful lives for                 
                property, equipment and capitalized software                     
                (Details)                                                        
38: R42         Basis of Presentation, Uses of Estimates and        HTML     53K 
                Significant Accounting Policies Redeemable                       
                Noncontrolling Interests (Details)                               
48: R43         Investments (Narrative) (Details)                   HTML     36K 
52: R44         Investments (Short-Term and Long-Term Investments)  HTML    137K 
                (Details)                                                        
63: R45         Investments (Fair Value of Mortgage-Backed          HTML    114K 
                Securities by Credit Rating Origination) (Details)               
24: R46         Investments (Amortized Cost and Fair Value of       HTML     87K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
44: R47         Investments (Amortized Cost and Fair Value of       HTML     66K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
19: R48         Investments (Fair Value of Available-For-Sale       HTML    117K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
99: R49         Investments (Net Realized Gains) (Details)          HTML     72K 
37: R50         Fair Value (Narrative) (Details)                    HTML     61K 
96: R51         Fair Value (Financial Assets and Liabilities,       HTML    145K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
41: R52         Fair Value (Financial Assets and Liabilities,       HTML    127K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
60: R53         Fair Value (Reconciliation of Assets Measured at    HTML     98K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
18: R54         Fair Value Fair Value Inputs Assets Quantitative    HTML     52K 
                Information (Details)                                            
22: R55         Fair Value (Assets and Liabilities measured at      HTML    189K 
                fair value on a recurring basis) (Details)                       
51: R56         Property, Plant, and Capitalized Software           HTML     38K 
                (Details)                                                        
29: R57         Property, Plant, and Capitalized Software Property  HTML     62K 
                Plant and Equipment Table (Details)                              
104: R58         Goodwill and Intangible Assets (Details)            HTML     36K  
65: R59         Goodwill and Intangible Assets Changes in the       HTML     64K 
                Carrying Amount of Goodwill by Reporting Segment                 
                (Details)                                                        
87: R60         Goodwill and Intangible Assets Gross carrying       HTML     63K 
                value, accumulated amortization and net carrying                 
                value of intangible assets (Details)                             
43: R61         Goodwill and Intangible Assets Weighted-average     HTML     48K 
                useful lives assigned to finite-lived intangible                 
                assets acquired in business combinations (Details)               
46: R62         Goodwill and Intangible Assets Amortization         HTML     45K 
                Expense relating to Intangible Assets (Details)                  
94: R63         Medical Costs and Medical Costs Payable             HTML     58K 
                Rollforward (Details)                                            
91: R64         Commercial Paper and Long-Term Debt (Narrative)     HTML     73K 
                (Details)                                                        
67: R65         Commercial Paper and Long-Term Debt (Details)       HTML    271K 
93: R66         Commercial Paper and Long-Term Debt Maturities of   HTML     51K 
                commercial paper and long-term debt (Details)                    
42: R67         Commercial Paper and Long-Term Debt Fair Value      HTML     46K 
                Hedges Statement of Financial Position Location                  
                (Details)                                                        
71: R68         Commercial Paper and Long-Term Debt Fair Value      HTML     48K 
                Hedges Effect of Changes in Fair Value Hedges on                 
                Income (Details)                                                 
106: R69         Income Taxes (Details)                              HTML     64K  
21: R70         Income Taxes Reconciliation of Provision for        HTML     54K 
                Income Taxes (Details)                                           
35: R71         Income Tax Reconciliation of the tax provision at   HTML     84K 
                the U.S. Federal Statutory Rate (Details)                        
61: R72         Income Taxes Components of Deferred Tax Assets and  HTML    102K 
                Liabilities (Details)                                            
27: R73         Income Taxes Reconciliation of the beginning and    HTML     53K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
109: R74         Shareholders' Equity (Details)                      HTML     70K  
39: R75         Shareholders' Equity Dividends Paid (Details)       HTML     38K 
30: R76         Share-Based Compensation Narrative (Details)        HTML     44K 
34: R77         Share-Based Compensation (Stock Option and SAR      HTML     86K 
                Activity) (Details)                                              
23: R78         Share-Based Compensation (Restricted Share          HTML     53K 
                Activity) (Details)                                              
26: R79         Share-Based Compensation Other Share-Based          HTML     75K 
                Compensation Data (Details)                                      
78: R80         Share-Based Compensation (Share-Based Compensation  HTML     64K 
                Principal Fair Value Assumptions) (Details)                      
32: R81         Commitments and Contingencies (Details)             HTML     70K 
105: R82         Commitments and Contingencies Future Lease          HTML     50K  
                Payments (Details)                                               
58: R83         Segment Financial Information (Narrative)           HTML     49K 
                (Details)                                                        
85: R84         Segment Financial Information (Details)             HTML    261K 
92: R85         Quarterly Financial Data (Unaudited) (Details)      HTML     87K 
31: R86         Schedule I (Details)                                HTML     65K 
33: R87         Schedule I Condensed Balance Sheets (Details)       HTML    132K 
102: R88         Schedule I Balance Sheet Document (Details)         HTML     64K  
28: R89         Schedule I Condensed Statement of Comprehensive     HTML     88K 
                Income (Details)                                                 
79: R90         Schedule I Statement of Cash Flows (Details)        HTML    127K 
75: R91         Schedule I Maturities of Commercial Paper and       HTML     56K 
                Long-Term Debt (Details)                                         
108: XML         IDEA XML File -- Filing Summary                      XML    169K  
20: EXCEL       IDEA Workbook of Financial Reports                  XLSX    447K 
47: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   4.36M 
11: EX-101.INS  XBRL Instance -- unh-20141231                        XML   6.68M 
13: EX-101.CAL  XBRL Calculations -- unh-20141231_cal                XML    313K 
14: EX-101.DEF  XBRL Definitions -- unh-20141231_def                 XML   1.53M 
15: EX-101.LAB  XBRL Labels -- unh-20141231_lab                      XML   2.64M 
16: EX-101.PRE  XBRL Presentations -- unh-20141231_pre               XML   1.75M 
12: EX-101.SCH  XBRL Schema -- unh-20141231                          XSD    252K 
56: ZIP         XBRL Zipped Folder -- 0000731766-15-000007-xbrl      Zip    458K 


‘R24’   —   Fair Value Fair Value (Policies)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.1.9
Fair Value Fair Value (Policies)
12 Months Ended
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Fair Value Measurement, Policy [Policy Text Block]
Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.
The fair value hierarchy is summarized as follows:
Level 1 — Quoted prices (unadjusted) for identical assets/liabilities in active markets.
Level 2 — Other observable inputs, either directly or indirectly, including:
Quoted prices for similar assets/liabilities in active markets;
Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);
Inputs other than quoted prices that are observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and
Inputs that are corroborated by other observable market data.
Level 3 — Unobservable inputs that cannot be corroborated by observable market data.
Transfers between levels, if any, are recorded as of the beginning of the reporting period in which the transfer occurs; there were no transfers between Levels 1, 2 or 3 of any financial assets or liabilities during 2014 or 2013.
Nonfinancial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the years ended December 31, 2014 or 2013.
The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:
Cash and Cash Equivalents. The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.
Debt and Equity Securities. Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company’s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment in the prices obtained from the pricing service.
Fair values of debt securities that do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level 2.
Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices.
The fair values of Level 3 investments in venture capital portfolios are estimated using a market valuation technique that relies heavily on management assumptions and qualitative observations. Under the market approach, the fair values of the Company’s various venture capital investments are computed using limited quantitative and qualitative observations of activity for similar companies in the current market. The Company’s market modeling utilizes, as applicable, transactions for comparable companies in similar industries that also have similar revenue and growth characteristics and preferences in their capital structure. Key significant unobservable inputs in the market technique include implied earnings before interest, taxes, depreciation and amortization (EBITDA) multiples and revenue multiples. Additionally, the fair values of certain of the Company’s venture capital securities are based on recent transactions in inactive markets for identical or similar securities. Significant changes in any of these inputs could result in significantly lower or higher fair value measurements.
Throughout the procedures discussed above in relation to the Company’s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on that understanding.
Other Assets. The fair values of the Company’s other assets are estimated and classified using the same methodologies as the Company’s investments in debt securities.
AARP Program-Related Investments. AARP Program-related investments consist of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company’s investments in debt and equity securities.
Interest Rate Swaps. Fair values of the Company’s swaps are estimated using the terms of the swaps and publicly available information including market yield curves. Because the swaps are unique and not actively traded but are valued using other observable inputs, the fair values are classified as Level 2.
Long-Term Debt. The fair values of the Company’s long-term debt are estimated and classified using the same methodologies as the Company’s investments in debt securities.
AARP Program-Related Other Liabilities. AARP Program-related other liabilities consist of liabilities that represent the amount of net investment gains and losses related to AARP Program-related investments that accrue to the benefit of the AARP policyholders.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/10/153,  4,  8-K
For Period end:12/31/1411-K,  ARS
 List all Filings 
Top
Filing Submission 0000731766-15-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 3:47:48.1pm ET